Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.
Haematologica
; 100(1): 77-86, 2015 Jan.
Article
in En
| MEDLINE
| ID: mdl-25344523
Full text:
1
Database:
MEDLINE
Main subject:
Purines
/
Pyrazoles
/
Pyrimidines
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Lymphoma, B-Cell
/
Antigens, CD20
/
Quinazolinones
/
Antibodies, Monoclonal
/
Antibody-Dependent Cell Cytotoxicity
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2015
Type:
Article
Affiliation country:
Italy